Basic Information
Corvia Medical, Inc. is committed to revolutionizing the treatment of heart failure through first-class structural heart devices. The company has developed the world's first transcatheter treatment device designed to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction, formerly known as diastolic heart failure (DHF).
Corvia Medical, Inc.
Massachusetts,United States of America
15~50 people
January 01, 2009
info@corviamedical.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios